Martin Norin
Chief Operating Officer presso KANCERA AB
Posizioni attive di Martin Norin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KANCERA AB | Chief Operating Officer | - | - |
Storia della carriera di Martin Norin
Precedenti posizioni note di Martin Norin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Pharmacia AB | Corporate Officer/Principal | - | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - | - |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The private company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Director/Board Member | 10/05/2011 | - |
| Chief Tech/Sci/R&D Officer | 10/05/2011 | - | |
| Founder | 10/05/2011 | 05/06/2012 |
Formazione di Martin Norin
| Royal Institute of Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 6 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KANCERA AB | Health Technology |
| Aziende private | 3 |
|---|---|
| Pharmacia AB | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The private company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
- Borsa valori
- Insiders
- Martin Norin
- Esperienza
